NCT02739815View on ClinicalTrials.gov

Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Hemorrhage of Cesarean Section and/or Perineal WoundPostpartum Hemorrhage
Interventions
DRUG

Normal Saline containing a prophylactic Antibiotic 1 g

500 ml of normal saline containing a prophylactic Antibiotic 1 g.

DRUG

Tranexamic Acid

Tranexamic acid

Trial Locations (1)

Unknown

Al-Azhar University, Faculty of Medicine for Boys ( Cairo ), Al-Hussein University Hospital, Cairo

All Listed Sponsors
collaborator

Al-Azhar University

OTHER

lead

Talkha Central Hospital

OTHER_GOV

NCT02739815 - Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section | Biotech Hunter | Biotech Hunter